Literature DB >> 3885008

Viral and cellular fos proteins are complexed with a 39,000-dalton cellular protein.

T Curran, C Van Beveren, I M Verma.   

Abstract

The structure of viral and cellular fos gene products and their association with a 39,000-dalton cellular protein (p39) were investigated by using antisera raised against synthetic peptides. The first peptide, termed M, corresponded to amino acids 127 to 152 of the v-fos sequence, a region which is identical in c-fos. The second peptide, termed V, corresponded to the nine C-terminal amino acids of v-fos; this region is not present in c-fos. Rabbit antisera were purified by affinity chromatography against their respective peptides before being used for immunoprecipitation. M peptide antisera precipitated p55v-fos and p55c-fos, whereas V peptide antisera precipitated only p55v-fos. This observation confirms the prediction from nucleotide sequence analysis that these proteins are distinct at their C termini. p39 was precipitated in association with p55v-fos and p55c-fos by M and V peptide antisera. However, V peptide antisera did not precipitate p39 from cells expressing p55c-fos, even though the presence of p39 in such cells was demonstrated with M peptide antisera. Denaturation of cell lysates completely abolished the precipitation of p39, whereas the precipitation of p55v-fos was unaffected. Taken together, the data demonstrate that p39 exists in a complex with p55.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3885008      PMCID: PMC366691          DOI: 10.1128/mcb.5.1.167-172.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  24 in total

1.  Transformation by Rous sarcoma virus: effects of src gene expression on the synthesis and phosphorylation of cellular polypeptides.

Authors:  K Radke; G S Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

2.  Transformation of mammalian cells by avian myelocytomatosis virus and avian erythroblastosis virus.

Authors:  K Quade
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

Review 3.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Solid phase synthesis of somatostatin-28.

Authors:  N Ling; F Esch; D Davis; M Mercado; M Regno; P Bohlen; P Brazeau; R Guillemin
Journal:  Biochem Biophys Res Commun       Date:  1980-08-14       Impact factor: 3.575

6.  The specific interaction of the Rous sarcoma virus transforming protein, pp60src, with two cellular proteins.

Authors:  J S Brugge; E Erikson; R L Erikson
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

7.  Enemies within: the genesis of retrovirus oncogenes.

Authors:  J M Bishop
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

8.  Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol.

Authors:  Y Sugimoto; M Whitman; L C Cantley; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Vinculin: a cytoskeletal target of the transforming protein of Rous sarcoma virus.

Authors:  B M Sefton; T Hunter; E H Ball; S J Singer
Journal:  Cell       Date:  1981-04       Impact factor: 41.582

10.  Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia.

Authors:  T J Gonda; D Metcalf
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

View more
  67 in total

1.  Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein.

Authors:  P A Ney; B P Sorrentino; C H Lowrey; A W Nienhuis
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

2.  Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1.

Authors:  U Müller; T Kleinberger; T Shenk
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Immunohistochemical detection of c-fos proteins in cultured human glial cells--induction by cyclic AMP and phorbol ester.

Authors:  J Koistinaho; M Koljonen; R Roivainen; T Metsä-Ketelä; A Hervonen
Journal:  Histochemistry       Date:  1990

4.  Semirational design of Jun-Fos coiled coils with increased affinity: Universal implications for leucine zipper prediction and design.

Authors:  Jody M Mason; Mark A Schmitz; Kristian M Müller; Katja M Arndt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

5.  Regulation of a fos-lacZ fusion gene: a paradigm for quantitative analysis of stimulus-transcription coupling.

Authors:  K Schilling; D Luk; J I Morgan; T Curran
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

6.  Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.

Authors:  T Hai; T Curran
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

7.  Association of adenovirus early-region 1A proteins with cellular polypeptides.

Authors:  E Harlow; P Whyte; B R Franza; C Schley
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

8.  The bZIP domains of Fos and Jun mediate a physical association with the TATA box-binding protein.

Authors:  L J Ransone; L D Kerr; M J Schmitt; P Wamsley; I M Verma
Journal:  Gene Expr       Date:  1993

9.  Analysis of AP-1 function in cellular transformation pathways.

Authors:  T Suzuki; M Murakami; N Onai; E Fukuda; Y Hashimoto; M H Sonobe; T Kameda; M Ichinose; K Miki; H Iba
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Light and electron microscopic evidences of the presence of c-fos-like immunoreactivity in the rat adrenal cortex.

Authors:  G Yang; J Koistinaho; S Zhu; A Hervonen
Journal:  Histochemistry       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.